The Molecular Basis of Hematologic Malignancies

This course examines molecular mechanisms of hematologic malignancies and how laboratory assays guide diagnosis and therapy.

offering recorded2 credits
Recorded instructors · Spring 2027 No instructors listed

Summary

What you’ll be able to do

  • Describe basic processes underlying normal hematopoiesis and lymphocyte development.

  • Apply basic principles, advantages, and limitations of the most common forms of ancillary testing in hematopathology, including flow cytometry, cytogenetics/FISH, and select molecular assays.

  • Explain types of molecular abnormalities observed in neoplasia and how these abnormalities contribute to neoplastic growth via various cellular pathways.

  • Describe the molecular basis, pathophysiology, and laboratory evaluation of known or suspected myeloid malignancies (including MDS, MPN, MDS/MPN, AML, and systemic mastocytosis)

  • Describe the molecular basis and pathophysiology of clonal hematopoiesis of indeterminate potential (CHIP) and clonal cytopenia of uncertain significance (CCUS), and understand how these entities may complicate the molecular evaluation of suspected myeloid malignancies.

  • Describe the molecular basis, pathophysiology, and laboratory testing of lymphoid malignancies, including lymphoblastic lymphomas/leukemias and B-cell and T-cell lymphomas.

  • Describe the role of precision medicine and the utility of current and evolving targeted therapies in hematolymphoid disorders.

Source: UW Guide

Grade history

↗
average GPA
letter grades

No recorded grade history.

All recorded terms · compare terms & instructors

Prerequisites

Course map

MED SC-M 810, 811, 812, and 813

This is a best-effort interpretation; check the catalog requirements above.

Prerequisite text tree

Professors

Spring 2027

No instructors recorded for this selection.

Historical instructors & teaching patterns

Recorded history may be incomplete and does not establish a future schedule.

Calendar & sections

Spring 2027

Schedule loads here as you scroll.

SectionModeEnrolled / capacityWaitlist
LEC 004Classroom Instruction0 / 40
LEC 007Classroom Instruction0 / 40

Times are Central. Select a meeting for details; export includes recorded dates for the selected sections. Enrollment reflects scan time.

Meeting source records

Student experience

the class

Understanding molecular mechanisms of hematologic disease, and developing a foundation in the principles of relevant molecular assays, is critical to providing appropriate patient care. Topics include bases of neoplastic disorders of the hematopoietic and lymphoid systems, how underlying molecular abnormalities contribute to the pathophysiology of these diseases, and the evolving spectrum of molecular and cytogenetic/FISH testing and other ancillary testing (such as flow cytometry), which are often utilized in the work-up of hematopoietic and lymphoid malignancies. Learn about strengths and weaknesses of these technologies, and how pathologists integrate results of molecular testing with the traditional histologic exam to produce accurate diagnoses and drive clinical decision making. Develop an understanding of how knowing the underlying molecular pathology of a hematopoietic or lymphoid malignancy can inform prognosis and guide therapy.

difficulty & workload

No workload feedback recorded.

Topics

  • Neoplastic disorders of the hematopoietic and lymphoid systems.
  • Molecular abnormalities that drive pathophysiology.
  • Molecular, cytogenetic/FISH, and flow cytometry testing.
  • Myeloid malignancies including MDS, MPN, MDS/MPN, AML, and systemic mastocytosis.
  • Lymphoid malignancies and their laboratory evaluation.
  • Precision medicine and targeted therapies in hematolymphoid disorders.

Skills

  • Integrate molecular test results with histologic examination to support diagnosis.
  • Apply principles, advantages, and limitations of hematopathology assays.
  • Use molecular pathology findings to inform prognosis and therapy.

Grades

Instructor

Grade distribution · % of letter grades

No grades available yet.

More grade details Grade mix, volume & source data

Sources & history

UW–Madison

Catalog & offerings

Descriptions, prerequisites, and recorded course offerings.

Catalog observation history

Observations at scan time; dates do not imply when a catalog change took effect.

Selected offering source records
PATH 962 · Spring 2027

The Molecular Basis of Hematologic Malignancies

Recorded 2026-10-14
Raw records
[
  {
    "run_id": "20261014T203208-0851c9a1",
    "semester": "1274",
    "observed_at": "2026-10-14 17:50:09.728220+00:00",
    "offering_id": "1274:704:025926",
    "course_id": "PATH 962",
    "course_uid": "course_02e4dfa11375de8c0eb35581",
    "term_id": "1274",
    "source_course_id": "025926",
    "source_subject_id": "704",
    "title": "The Molecular Basis of Hematologic Malignancies",
    "credits_min": 2,
    "credits_max": 2,
    "typically_offered": "Not Applicable"
  }
]
Rate My Professors

Student reviews

Original comments behind the course and instructor summaries.

Read original reviews

No records available.

Madgrades

Grade history

Recorded grade distributions by term, section, and instructor.

Explore recorded grades
Model outputs & technical records
Qwen/Qwen3.8-27B
LLM outputs across runs
Full model traces

Recorded model configuration, reasoning, and tool conversations.

Model & dataset provenance
{
  "model": "Qwen/Qwen3.8-27B",
  "model_revision": "1d4bf0f2ff6012fd82039f2fa52739d0dd7c60c0",
  "task_version": "17",
  "output_id": "24a76e4d86a9891781923c67e11c22ba2792dece791f82b521b04f2a56cad691",
  "requirements_status": "valid",
  "dataset_revision": "fc1811fa52e581ea57a35c0cf3343f8740a8ffbf",
  "observed_at": "2026-10-14 17:50:09.728220+00:00"
}